Aster DM Quality Care Q2 net profit more than doubles to ₹262 crore
Aster DM Quality Care reported results for Q2FY27.
· BS Companies
The hospital chain reported revenue of ₹2,829 crore in Q2FY27, driven by higher patient volumes, improved occupancy, complex procedures and growth in medical value…
Key facts
- Period
- Q2FY27
The analysis
Aster DM Quality Care reported ₹262 crore and ₹2,829 crore for Q2FY27. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Against that, the stock is -0.9% on the day at ₹713.15, and has returned -15.6% over three months. It sits 18% below its 52-week high. The pharma & healthcare sector has moved +1.4% over the same period, so Aster DM Quality Care is running 16.9 points behind its peers.
For Aster DM Quality Care, the question is how much of this is already reflected in the price and how much re-rates the pharma & healthcare peer set alongside it.
Why it matters
- Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
Market context
- In focus: Aster DM Quality Care (ASTERDM), in Pharma & Healthcare.
- Over three months: Aster DM Quality Care -15.6% against Pharma & Healthcare +1.4% (16.9 points behind).
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| Aster DM Quality CareASTERDM · Pharma & Healthcare | ₹713.15 | -0.9% | +4.2% | -15.6% | -18.0% | 1.3× | — |
Pharma & Healthcare
1M +3.0% · 3M +1.4%
Aster DM Quality Care
Prices as of 6 Nov 2026, 16:10 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Gland Pharma Q2FY27 results: Net profit rises 58% to ₹290.75 crore
Q2 results, order win drive Symbiotec Pharma 20% higher to new high
Fortis Q2 net profit falls 2.5% on higher expenses, lower exceptional gain
Apollo's Bangladesh patient revenue nears pre-crisis peak of ₹450 crore
Glenmark Pharma Q2 revenue falls 30% to ₹4,247 crore, profit down 57%